Cargando…
GABA administration prevents severe illness and death following coronavirus infection in mice
There is an urgent need for new treatments to prevent and ameliorate severe illness and death induced by SARS-CoV-2 infection in COVID-19 patients. The coronavirus mouse hepatitis virus (MHV)-1 causes pneumonitis in mice which shares many pathological characteristics with human SARS-CoV infection. P...
Autores principales: | Tian, Jide, Middleton, Blake, Kaufman, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536896/ https://www.ncbi.nlm.nih.gov/pubmed/33024975 http://dx.doi.org/10.1101/2020.10.04.325423 |
Ejemplares similares
-
GABA(A)-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice
por: Tian, Jide, et al.
Publicado: (2021) -
GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models
por: Song, Min, et al.
Publicado: (2022) -
A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice
por: Tian, Jide, et al.
Publicado: (2022) -
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017) -
The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
por: Tian, Jide, et al.
Publicado: (2023)